It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Rebecca Robertson Biography and Net Worth

Director of Tandem Diabetes Care

Ms. Robertson has served on our board of directors since January 2019. Ms. Robertson is a founder and Managing Director at Versant Ventures where she has specialized in investing in the areas of medical devices and diagnostics since 1999. In addition, through Longridge Business Advisors, she has provided business advisory services and board services since April 2017. Prior to Versant, she served as Senior Vice President at Chiron Diagnostics, a division of Chiron Corporation, where she had responsibility for the critical care business unit in addition to leading the division’s business development efforts. Prior to joining Chiron, Ms. Robertson was a co-founder and Vice President at Egis, a consumer products company, and held senior management positions in operations and finance at Lifescan, a Johnson & Johnson Company. Ms. Robertson served as a general partner at Institutional Venture Partners (IVP), where she was an investor in the life sciences group, from July 1997 to October 1999. Ms. Robertson was also previously an entrepreneur in residence for IVP in the life sciences group. Ms. Robertson holds a B.S. in Chemical Engineering from Cornell University.

What is Rebecca B. Robertson's net worth?: The estimated net worth of Rebecca B. Robertson is at least $66,665.04 as of June 9th, 2021. Ms. Robertson owns 2,392 shares of Tandem Diabetes Care stock worth more than $66,665 as of November 19th. This net worth approximation does not reflect any other assets that Ms. Robertson may own. Learn More about Rebecca B. Robertson's net worth.
How do I contact Rebecca B. Robertson?: The corporate mailing address for Ms. Robertson and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected]. Learn More on Rebecca B. Robertson's contact information.
Has Rebecca B. Robertson been buying or selling shares of Tandem Diabetes Care?: Rebecca B. Robertson has not been actively trading shares of Tandem Diabetes Care during the last quarter. Most recently, Rebecca B. Robertson sold 1,500 shares of the business's stock in a transaction on Monday, May 2nd. The shares were sold at an average price of $96.73, for a transaction totalling $145,095.00. Learn More on Rebecca B. Robertson's trading history.
Who are Tandem Diabetes Care's active insiders?: Tandem Diabetes Care's insider roster includes David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.
Are insiders buying or selling shares of Tandem Diabetes Care?: In the last twelve months, Tandem Diabetes Care insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $94,800.00. In the last twelve months, insiders at the medical device company sold shares 1 times. They sold a total of 5,000 shares worth more than $258,400.00. The most recent insider tranaction occured on May, 30th when Director Dick Allen sold 5,000 shares worth more than $258,400.00. Insiders at Tandem Diabetes Care own 2.2% of the company. Learn More about insider trades at Tandem Diabetes Care.
Information on this page was last updated on 5/30/2024.

Rebecca B. Robertson Insider Trading History at Tandem Diabetes Care

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/2/2022	Sell	1,500	$96.73	$145,095.00
2/1/2022	Sell	1,500	$117.97	$176,955.00
11/1/2021	Sell	1,500	$135.77	$203,655.00
8/2/2021	Sell	1,500	$107.51	$161,265.00
6/9/2021	Sell	500	$90.00	$45,000.00	2,392
9/2/2020	Sell	9,500	$114.14	$1,084,330.00	9,500

Rebecca B. Robertson Buying and Selling Activity at Tandem Diabetes Care

Tandem Diabetes Care Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Today's Range

Now: $27.87

$27.66

$28.60

50 Day Range

MA: $37.19

$27.34

$45.44

2 Week Range

Now: $27.87

$17.33

$53.69

Volume

1,344,288 shs

Average Volume

1,604,687 shs

Market Capitalization

$1.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Tesla Execs are Freaking Out

From Angel Publishing | Ad

Click here to get the details.